Meissner WG, Remy P, Giordana C, Maltete D, Derkinderen P, Houeto JL, Anheim M, Benatru I, Boraud T, Brefel-Courbon C, Carriere N, Catala H, Colin O, Corvol JC, Damier P, Dellapina E, Devos D, Drapier S, Fabbri M, Ferrier V, Foubert-Samier A, Frismand-Kryloff S, Georget A, Germain C, Grimaldi S, Hardy C, Hopes L, Krystkowiak P, Laurens B, Lefaucheur R, Mariani LL, Marques A, Marse C, Ory-Magne F, Rigalleau V, Salhi H, Saubion A, Stott SRW, Thalamas C, Thiriez C, Tir M, Wyse RK, Benard A, Rascol O, Group LS (2024) Trial of Lixisenatide in early Parkinsons disease
Compare and Contrast the Glucagon-Like Peptide-1 Receptor Agonists (GLP1RAs) [Updated 2023 Mar 27]
Primary carnitine deficiency (PCD) is an autosomal recessive FA oxidation disease (71), leading to increased ROS production (72)
Novo Nordisk said it is working diligently to address the concerns
They may be triggered by gastrointestinal issues, neurological diseases, autoimmune conditions, or even certain foods and medications
Personal Opinion: The energy improvements I have observed in menopausal women using Retatrutide often exceed what weight loss alone would explain